Hosted on MSN18d
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domainand potential active site cavities were predicted within the RBD structure. Among the seven drugs tested, only lopinavir and ritonavir demonstrated significant binding affinities to the RBD. Lopinavir ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback